Healthcare Services

Artificial Intelligence In Life Sciences Market Expected to Record Steady Growth and Approach $10.42 Billion by 2030

March 30, 2026March 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Large Is The Artificial Intelligence In Life Sciences Market Projected To Become By 2030 Based On Its 2026 Valuation?

The artificial intelligence in life sciences market size has grown exponentially in recent years. It will grow from $3.59 billion in 2025 to $4.44 billion in 2026 at a compound annual growth rate (CAGR) of 23.6%. The growth in the historic period can be attributed to increasing complexity of biological datasets, expansion of genomics research, rising adoption of digital lab technologies, early integration of ai in biotechnology research, growing demand for faster research cycles.

The artificial intelligence in life sciences market size is anticipated to undergo substantial growth in the upcoming years. It is projected to swell to $10.43 billion by 2030, achieving a compound annual growth rate (CAGR) of 23.8%. This expansion during the forecast period is attributable to several factors, including heightened investments in personalized medicine, the increasing deployment of AI-enabled laboratory automation, the broadening reach of cloud-based life science platforms, strengthening partnerships between technology and life science firms, and a growing regulatory acceptance of AI-driven insights. Key trends for the forecast period include the deeper integration of AI across life science workflows, the rising uptake of AI-driven data analytics platforms, the expanded use of automation in laboratory operations, the proliferation of AI-based precision medicine applications, and an enhanced focus on expediting research outcomes.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13587&type=smp

What Drivers Are Shaping The Future Growth Of The Artificial Intelligence In Life Sciences Market?

The rising demand for real-time remote patient monitoring (RPM) systems is anticipated to fuel the expansion of artificial intelligence within the life sciences market moving ahead. An RPM system represents a technology-powered healthcare solution specifically developed to oversee patients’ well-being beyond conventional medical environments. Artificial intelligence in life sciences plays a crucial role in remote patient monitoring, offering ongoing, tailored, and data-informed insights that facilitate proactive healthcare management. As an illustration, in April 2025, the Peterson Center on Healthcare, a US-based non-profit organization, documented that expenditures for remote therapeutic monitoring (RTM) within Traditional Medicare increased substantially from $2.2 million in 2022 to $10.4 million in 2023. Additionally, during 2023, Traditional Medicare saw 451,000 patients utilizing RPM services. Consequently, the heightened enthusiasm for real-time remote patient monitoring (RPM) systems is propelling the expansion of artificial intelligence in the life sciences market.

What Segment Groups Are Identified Within The Artificial Intelligence In Life Sciences Market?

The artificial intelligence in life sciences market covered in this report is segmented –

1) By Offering: Software, Hardware, Services

2) By Deployment: On-Premises, Cloud-Based

3) By Application: Drug Discovery, Medical Diagnosis, Biotechnology, Clinical Trials, Precision And Personalized Medicine, Patient Monitoring

Subsegments:

1) By Software: Drug Discovery Software, Genomic Analysis Software, Clinical Trial Management Software, Personalized Medicine Software, Laboratory Information Management Systems (LIMS)

2) By Hardware: AI-Enabled Laboratory Equipment, Robotics And Automation Systems, Imaging Devices And Equipment, Sensor Technologies

3) By Services: Consulting Services, Data Analytics Services, Research And Development Services, Implementation And Integration Services, Training And Support Services

What Key Trends Are Influencing The Development Of The Artificial Intelligence In Life Sciences Market?

Leading companies active in the artificial intelligence in the life sciences market are concentrating on developing innovative products featuring technological progress, such as drug discovery software, to secure their market position. Drug discovery software refers to a range of computer programs and applications crafted to support pharmaceutical and biotechnology researchers in the process of discovering new medications. For example, in December 2023, Merck, a science and technology firm based in Germany, introduced AIDDISON, a pioneering drug discovery software. Unique as the first of its kind, it connects virtual molecule design with practical manufacturability, utilizing generative AI, machine learning, and computer-aided drug design. AIDDISON efficiently identifies potential drug candidates from numerous options, considering vital characteristics like non-toxicity and solubility. Its capacity to bridge the gap between theoretical molecule design and real-world production viability is a notable application of artificial intelligence in the life sciences sector.

Which Companies Hold Significant Positions In The Artificial Intelligence In Life Sciences Market?

Major companies operating in the artificial intelligence in life sciences market are Google LLC, Microsoft Corporation, Intel Corporation, IBM Corporation, Medtronic PLC, Nvidia Corporation, Novo Nordisk A/S, Siemens Healthineers AG, Philips Healthcare, Babylon Healthcare Services Ltd., Komodo Health Inc., Modernizing Medicine Inc., Viz.ai Inc., Butterfly Network Inc., Augmedix, AiCure LLC, HealthTap Inc., Welltok Inc., Enlitic Inc., PathAI Inc., Nano-X Imaging Ltd., Berg LLC, Insitro, Sense.ly Inc., Subtle Medical Inc., Medasense Biometrics Limited, Immunai, Atomwise Inc., Freenome Holdings Inc., CloudMedX Inc.

Read the full artificial intelligence in life sciences market report here:

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-life-sciences-global-market-report

Which Geographic Regions Are Influencing Demand In The Artificial Intelligence In Life Sciences Market?

North America was the largest region in the Artificial Intelligence In Life Sciences market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in life sciences market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Artificial Intelligence In Life Sciences Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13587&type=smp

Browse Through More Reports Similar to the Global Artificial Intelligence In Life Sciences Market 2026, By The Business Research Company

Ai In Life Science Analytics Global Market Report

https://www.thebusinessresearchcompany.com/report/ai-in-life-science-analytics-global-market-report

Artificial Intelligence In Medicine Global Market Report

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-medicine-global-market-report

Life Science Analytics Global Market Report

https://www.thebusinessresearchcompany.com/report/life-science-analytics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795